Urinary prostaglandin D 2 and E 2 metabolites are elevated with disease severity in patients with Fu...
Urinary prostaglandin D 2 and E 2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy
About this item
Full title
Author / Creator
Publisher
England
Journal title
Language
English
Formats
Publication information
Publisher
England
Subjects
More information
Scope and Contents
Contents
Treatment approaches are lacking for Fukuyama congenital muscular dystrophy (FCMD), the second most common type of pediatric muscular dystrophy after Duchenne muscular dystrophy (DMD) in the Japanese population. Recent studies demonstrating the involvement of prostaglandin (PG) D
in DMD progression has led to the development of novel inhibitors...
Alternative Titles
Full title
Urinary prostaglandin D 2 and E 2 metabolites are elevated with disease severity in patients with Fukuyama congenital muscular dystrophy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_40011677
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_40011677
Other Identifiers
E-ISSN
2045-2322
DOI
10.1038/s41598-025-91539-2
